Harbor Capital Advisors’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Harbor Capital Advisors's AGL Position: Q1 2024 in Review
Harbor Capital Advisors sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 487 shares — an estimated $153K sold.
Harbor Capital Advisors first reported a position in AGL in Q1 2023 and held it in 4 quarters. The position peaked at $153K in Q4 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.
- Harbor Capital Advisors reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
- Harbor Capital Advisors sold 487 Agilon Health shares in Q1 2024, an estimated $153K.
- Harbor Capital Advisors first reported a position in Agilon Health in Q1 2023 and held it in 4 quarters.
- Harbor Capital Advisors's Agilon Health position peaked at $153K in Q4 2023.
- 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.
Based on Harbor Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.